TD Cowen Maintains Hold on Calumet, Raises Price Target to $40

Calumet, Inc.

Calumet, Inc.

CLMT

0.00

TD Cowen analyst Jason Gabelman maintains Calumet (NASDAQ: CLMT) with a Hold and raises the price target from $34 to $40.